137 related articles for article (PubMed ID: 10383137)
1. Identification of a transactivation activity in the COOH-terminal region of p73 which is impaired in the naturally occurring mutants found in human neuroblastomas.
Takada N; Ozaki T; Ichimiya S; Todo S; Nakagawara A
Cancer Res; 1999 Jun; 59(12):2810-4. PubMed ID: 10383137
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of naturally occurring mutants (P405R and P425L) of p73alpha and p73beta found in neuroblastoma and lung cancer.
Naka M; Ozaki T; Takada N; Takahashi M; Shishikura T; Sakiyama S; Tada M; Todo S; Nakagawara A
Oncogene; 2001 Jun; 20(27):3568-72. PubMed ID: 11429704
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the COOH-terminal region of p73alpha enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammalian cells.
Ozaki T; Naka M; Takada N; Tada M; Sakiyama S; Nakagawara A
Cancer Res; 1999 Dec; 59(23):5902-7. PubMed ID: 10606232
[TBL] [Abstract][Full Text] [Related]
4. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.
Di Como CJ; Gaiddon C; Prives C
Mol Cell Biol; 1999 Feb; 19(2):1438-49. PubMed ID: 9891077
[TBL] [Abstract][Full Text] [Related]
5. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
[TBL] [Abstract][Full Text] [Related]
6. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
Kim EJ; Park JS; Um SJ
Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
[TBL] [Abstract][Full Text] [Related]
7. Function of p73, not of p53, is inhibited by the physical interaction with RACK1 and its inhibitory effect is counteracted by pRB.
Ozaki T; Watanabe K; Nakagawa T; Miyazaki K; Takahashi M; Nakagawara A
Oncogene; 2003 May; 22(21):3231-42. PubMed ID: 12761493
[TBL] [Abstract][Full Text] [Related]
8. A naturally occurring p73 mutation in a p73-p53 double-mutant lung cancer cell line encodes p73 alpha protein with a dominant-negative function.
Huqun ; Endo Y; Xin H; Takahashi M; Nukiwa T; Hagiwara K
Cancer Sci; 2003 Aug; 94(8):718-24. PubMed ID: 12901798
[TBL] [Abstract][Full Text] [Related]
9. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent.
Ichimiya S; Nimura Y; Kageyama H; Takada N; Sunahara M; Shishikura T; Nakamura Y; Sakiyama S; Seki N; Ohira M; Kaneko Y; McKeon F; Caput D; Nakagawara A
Oncogene; 1999 Jan; 18(4):1061-6. PubMed ID: 10023682
[TBL] [Abstract][Full Text] [Related]
10. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73.
Ishimoto O; Kawahara C; Enjo K; Obinata M; Nukiwa T; Ikawa S
Cancer Res; 2002 Feb; 62(3):636-41. PubMed ID: 11830511
[TBL] [Abstract][Full Text] [Related]
11. Characterization of p73 functional domains necessary for transactivation and growth suppression.
Nozell S; Wu Y; McNaughton K; Liu G; Willis A; Paik JC; Chen X
Oncogene; 2003 Jul; 22(28):4333-47. PubMed ID: 12853970
[TBL] [Abstract][Full Text] [Related]
12. Identification of protein kinase A catalytic subunit beta as a novel binding partner of p73 and regulation of p73 function.
Hanamoto T; Ozaki T; Furuya K; Hosoda M; Hayashi S; Nakanishi M; Yamamoto H; Kikuchi H; Todo S; Nakagawara A
J Biol Chem; 2005 Apr; 280(17):16665-75. PubMed ID: 15723830
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the p53 mutants ability to inhibit p73 beta transactivation using a yeast-based functional assay.
Monti P; Campomenosi P; Ciribilli Y; Iannone R; Aprile A; Inga A; Tada M; Menichini P; Abbondandolo A; Fronza G
Oncogene; 2003 Aug; 22(34):5252-60. PubMed ID: 12917626
[TBL] [Abstract][Full Text] [Related]
14. p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y.
Hackzell A; Uramoto H; Izumi H; Kohno K; Funa K
J Biol Chem; 2002 Oct; 277(42):39769-76. PubMed ID: 12167641
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of p73 localized at chromosome 1p36.3 in primary neuroblastomas.
Ichimiya S; Nimura Y; Kageyama H; Takada N; Sunahara M; Shishikura T; Nakamura Y; Sakiyama S; Seki N; Ohira M; Kaneko Y; McKeon F; Caput D; Nakagawara A
Med Pediatr Oncol; 2001 Jan; 36(1):42-4. PubMed ID: 11464902
[TBL] [Abstract][Full Text] [Related]
16. Transactivation-dependent and -independent regulation of p73 stability.
Dulloo I; Sabapathy K
J Biol Chem; 2005 Aug; 280(31):28203-14. PubMed ID: 15919663
[TBL] [Abstract][Full Text] [Related]
17. A link between p73 transcriptional activity and p73 degradation.
Wu L; Zhu H; Nie L; Maki CG
Oncogene; 2004 May; 23(22):4032-6. PubMed ID: 15021899
[TBL] [Abstract][Full Text] [Related]
18. When p53 needs p73 to be functional - forced p73 expression induces nuclear accumulation of endogenous p53 protein.
Goldschneider D; Blanc E; Raguenez G; Haddada H; Bénard J; Douc-Rasy S
Cancer Lett; 2003 Jul; 197(1-2):99-103. PubMed ID: 12880967
[TBL] [Abstract][Full Text] [Related]
19. Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53.
Fillippovich I; Sorokina N; Gatei M; Haupt Y; Hobson K; Moallem E; Spring K; Mould M; McGuckin MA; Lavin MF; Khanna KK
Oncogene; 2001 Jan; 20(4):514-22. PubMed ID: 11313982
[TBL] [Abstract][Full Text] [Related]
20. p73 competes with p53 and attenuates its response in a human ovarian cancer cell line.
Vikhanskaya F; D'Incalci M; Broggini M
Nucleic Acids Res; 2000 Jan; 28(2):513-9. PubMed ID: 10606650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
